Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 1Phase 2/3 1Phase 1 1

Status

Unknown 29Completed 16Recruiting 14Withdrawn 5Not yet recruiting 5Terminated 4Active not recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 3Tumor-Agnostic 1Thoracic 1

Conditions

Esophageal Squamous Cell Carcinoma 3Esophageal Neoplasms 2Lung Neoplasms 1Carcinoma 1Adenocarcinoma 1

Interventions

pembrolizumab 61Radiotherapy 55Gemcitabine 51Paclitaxel 49Cyclophosphamide 48Cisplatin 48Carboplatin 45Dexamethasone 37Bevacizumab 37Nivolumab 35Fluorouracil 34Docetaxel 34Oxaliplatin 33durvalumab 32Rituximab 28Magnetic Resonance Spectroscopy 28Leucovorin 28Drug Therapy 25Pemetrexed 24Doxorubicin 24Capecitabine 24atezolizumab 22Radiation 20Cytarabine 20Radiosurgery 19Prednisone 19Etoposide 19Irinotecan 17Bortezomib 17Cetuximab 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Withdrawn × nimotuzumab × Clear all
NCT02428764 2024-12-10

Neoadjuvant Nimotuzumab Plus Gemcitabine and Carboplatin in Unresectable Stage III Squamous Cell Lung Carcinoma

Sun Yat-sen University

Phase 2 Withdrawn
Thoracic

Lung Neoplasms

NCT02034968 2015-03-05

Nimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal Carcinoma

Zhejiang University

Phase 2 Withdrawn
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT02041819 2015-03-05

Neoadjuvant Chemotherapy of Nimotuzumab Plus Nab-Paclitaxel in Squamous Cell Carcinoma of Esophagus

Zhejiang University

Phase 2 Withdrawn
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT02011594 2015-02-12

Phase II Study of Maintenance Treatment of Nimotuzumab for Advanced Esophageal Carcinoma

Zhejiang University

Phase 2 Withdrawn
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT01301612 2014-07-14

Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS)

Eurofarma Laboratorios S.A.

Phase 2 Withdrawn
Tumor-Agnostic

Adenocarcinoma, Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡